SSX7 anticorps (Middle Region)

N° du produit ABIN928570

Détail du produit anti-SSX7 anticorps

Antigène: SSX7 (Synovial Sarcoma, X Breakpoint 7 (SSX7))

Épitope: Middle Region

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp SSX7 est non-conjugé

Application: Western Blotting (WB)

Purification: Purified

Immunogène: SSX7 antibody was raised in rabbit using the middle region of SSX7 as the immunogen

Information d'application

Indications d'application: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Commentaires:

SSX7 Blocking Peptide, catalog no. 33R-3959, is also available for use as a blocking control in assays to test for specificity of this SSX7 antibody

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Concentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Détails sur SSX7

Antigène: SSX7 (Synovial Sarcoma, X Breakpoint 7 (SSX7))

Autre désignation: SSX7 (SSX7 Produits)

Synonymes: anticorps SSX family member 7, anticorps SSX7

Sujet: SSX7 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas. Synonyms: Polyclonal SSX7 antibody, Anti-SSX7 antibody, synovial sarcoma, X breakpoint 7 antibody.